Replies to post #25628 on Humanigen Inc (HGENQ)

[cowtown jay]

I kinda suspect that it's going to be more like the Aviptadil results, RLFTF drug being trial-sponsored in the US by NeuroRx. Didn't quite meet the primary endpoint for mortality due to improved SOC, but kicked butt on the secondary endpoints. I think CYDY and RLFTF will both get EUA's.